Practical Evaluation of Triple Therapy Efficacy and Biomarkers in 200 Elderly Patients with Real-World Bronchial Asthma and ACO
Background: In clinical trials for bronchial asthma and ACO, triple therapy (a combination of Inhaled Corticosteroids [ICS] + Long-Acting Beta-Agonists [LABA] + Long-Acting Anticholinergics [L...
Download PDF
Kenjiro Nagai* and Sho Nagai
